The molecular machinery of mitochondrial fusion and fission: An opportunity for drug discovery?

Zorzano A, SebastiĂĄn D, SegalĂŠs J, PalacĂ­n M

Novel role of FATP1 in mitochondrial fatty acid oxidation in skeletal muscle cells.

SebastiĂĄn D, Guitart M, GarcĂ­a-MartĂ­nez C, Mauvezin C, Orellana-GavaldĂ JM, Serra D, GĂłmez-Foix AM, Hegardt FG, Asins G

Carbon nanofiber growth optimization for their use as electrocatalyst support in proton exchange membrane (PEM) fuel cells.

LĂĄzaro MJ, SebastiĂĄn D, Suelves I, Moliner R

C75 is converted to C75-CoA in the hypothalamus, where it inhibits carnitine palmitoyltransferase 1 and decreases food intake and body weight.

Mera P, Bentebibel A, LĂłpez-ViĂąas E, Cordente AG, Gurunathan C, SebastiĂĄn D, VĂĄzquez I, Herrero L, Ariza X, GĂłmez-Puertas P, Asins G, Serra D, GarcĂ­a J, Hegardt FG

Muscle-specific IRS-1 Ser->Ala transgenic mice are protected from fat-induced insulin resistance in skeletal muscle.

Morino K, Neschen S, Bilz S, Sono S, Tsirigotis D, Reznick RM, Moore I, Nagai Y, Samuel V, Sebastian D, White M, Philbrick W, Shulman GI

CPT I overexpression protects L6E9 muscle cells from fatty acid-induced insulin resistance.

SebastiĂĄn D, Herrero L, Serra D, Asins G, Hegardt FG

HIV-related knowledge, attitudes, perceived benefits, and risks of HIV testing among pregnant women in rural Southern India.

Rogers A, Meundi A, Amma A, Rao A, Shetty P, Antony J, Sebastian D, Shetty P, Shetty AK

Novel effect of C75 on carnitine palmitoyltransferase I activity and palmitate oxidation.

Bentebibel A, SebastiĂĄn D, Herrero L, LĂłpez-ViĂąas E, Serra D, Asins G, GĂłmez-Puertas P, Hegardt FG

Thoraco lumbar junction syndrome: a case report.

Sebastian D

Alteration of the malonyl-CoA/carnitine palmitoyltransferase I interaction in the beta-cell impairs glucose-induced insulin secretion.

Herrero L, RubĂ­ B, SebastiĂĄn D, Serra D, Asins G, Maechler P, Prentki M, Hegardt FG

Lack of association of Human T-cell lymphotrophic virus type 1(HTLV-1) infection and rheumatoid arthritis in an endemic area.

Sebastian D, Nayiager S, York DY, Mody GM

Investigation of 4,5-epoxymorphinan degradation during analysis by HPLC.

Quarry MA, Sebastian DS, Diana F

Column selection and method development for the determination of the enantiomeric purity of investigational non-nucleoside reverse transcriptase inhibitors.

Aubry AF, Sebastian DS, Williams RC, Boucher RJ

In-use testing of extemporaneously prepared suspensions of second generation non-nucleoside reversed transcriptase inhibitors in support of phase I clinical studies.

Aubry AF, Sebastian D, Hobson T, Xu JQ, Rabel S, Xie M, Gray V

Development and validation of a reversed-phase liquid chromatographic method for analysis of aspirin and warfarin in a combination tablet formulation.

Montgomery ER, Taylor S, Segretario J, Engler E, Sebastian D